Overview Multicenter Trial For Patients With Acute Crohn's Disease Status: Completed Trial end date: 2004-01-01 Target enrollment: Participant gender: Summary The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease. Phase: Phase 2 Details Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.Teva Branded Pharmaceutical Products, R&D Inc.